Hypocalcaemia after treatment with [177Lu-DOTA 0,Tyr3]octreotate

2013 
Purpose The aim of this study was to explore the possible mechanisms involved in an observed decline in serum calcium levels in patients with a neuroendocrine tumour (NET) treated with [177Lu-DOTA0,Tyr3]octreotate (177Lu-octreotate).
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    16
    References
    4
    Citations
    NaN
    KQI
    []